Lifestance Health Group, INC Form 4 insider transactions

Pablo Pantaleoni, Chief Digital Officer of LifeStance Health Group, reports the withholding of shares to cover tax obligations upon the vesting of restricted stock units.

Ryan McGroarty, Chief Financial Officer and Treasurer of LifeStance Health Group, acquired 184,911 shares of common stock through restricted stock units on March 24, 2025.

Ryan McGroarty, CFO of LifeStance Health Group, received 362,844 restricted stock units (RSUs) on March 17, 2025, according to an amended SEC Form 4/A filing.

Ryan McGroarty, CFO of LifeStance Health Group, was granted stock options on March 17, 2025, including both time-vesting and performance-vesting options.

Lisa K. Miller, an executive at LifeStance Health Group, sold 18,845 shares of common stock at an average price of $6.90 on March 17, 2025.

Pablo Pantaleoni, Chief Digital Officer of LifeStance Health Group, reports changes in beneficial ownership of company stock due to RSU and PSU vesting and tax withholding.

Pablo Pantaleoni, Chief Digital Officer of LifeStance Health Group, sold shares of common stock on March 7 and March 10, 2025.

Lisa K. Miller, an executive at LifeStance Health Group, reports the acquisition of restricted stock units and the withholding of shares for tax obligations.

Pablo Pantaleoni, Chief Digital Officer of LifeStance Health Group, reports acquisition and disposal of common stock related to vesting of restricted stock units and performance-based restricted stock units.

Director Kenneth Burdick reports acquisition and disposal of LifeStance Health Group stock related to RSU and PSU vesting and tax withholding.

LifeStance Health Group's CEO, David Bourdon, reports acquisition and disposal of common stock due to vesting of restricted stock units (RSUs) and performance-based stock units (PSUs), with shares withheld for tax obligations.

Ujjwal Ramtekkar, Chief Medical Officer of LifeStance Health Group, reports acquisition and disposal of common stock and restricted stock units.

Ryan Pardo, Chief Legal Officer and Secretary of LifeStance Health Group, reports acquisition and disposal of company stock related to vesting of restricted stock units and performance-based stock units, primarily to cover tax obligations.

Ann Varanakis, Chief People Officer of LifeStance Health Group, reports acquisition and disposal of common stock related to vesting of restricted stock units and performance-based restricted stock units, with shares withheld for tax obligations.

LifeStance Health Group director Robert Bessler sold 75,000 shares of common stock on November 27, 2024, at an average price of $7.54 per share.

A LifeStance Health Group executive sold 10,540 shares of common stock to cover tax obligations related to vesting restricted stock units.

Director Teresa DeLuca acquired 35,211 shares of LifeStance Health Group, Inc. common stock on August 14, 2024, bringing her total holdings to 71,574 shares.

Director Teresa DeLuca acquired 36,363 restricted stock units in LifeStance Health Group, Inc.

Director Robert Bessler reports acquisition of 36,363 restricted stock units in LifeStance Health Group.

Director Eric Shuey reports acquisition of restricted stock units and disposition of common stock.

Director Seema Verma acquired 36,363 shares of LifeStance Health Group through restricted stock units on July 21, 2024.

William Joseph Miller, a director at LifeStance Health Group, acquired 36,363 restricted stock units on July 21, 2024.

Ann Varanakis, Chief People Officer of LifeStance Health Group, sold shares to cover tax withholding obligations related to vesting restricted stock units.

Danish J. Qureshi, President and COO of LifeStance Health Group, sold 150,000 shares of common stock at a price of $5.2101 per share on June 14, 2024, under a pre-planned trading plan.

LifeStance Health Group's Chief Legal Officer and Secretary, Ryan Pardo, sold shares to cover tax withholding obligations related to vesting restricted stock units.

Kevin Michael Mullins, Chief Development Officer of LifeStance Health Group, sold 85,093 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Danish J. Qureshi, President and COO of LifeStance Health Group, sold 83,109 shares of common stock at $5.25 to cover tax withholding obligations related to vesting restricted stock units.

Summit Partners Growth Equity Fund IX-A, L.P. and related entities sold 3,802,345 shares of LifeStance Health Group, Inc. at $5.89 per share on May 24, 2024.

Summit Partners L.P. and related entities sold 3,802,345 shares of LifeStance Health Group, Inc. at a price of $5.89 per share on May 24, 2024.

Director Jeffrey Crisan reports the sale of 1,624,638 shares of LifeStance Health Group, Inc. at $5.89 per share on May 24, 2024.